Rat Pneumonia and Soft-Tissue Infection Models for the Study of Acinetobacter baumannii Biology
- 9 June 2008
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 76 (8), 3577-3586
- https://doi.org/10.1128/iai.00269-08
Abstract
Acinetobacter baumannii is a bacterial pathogen of increasing medical importance. Little is known about its mechanisms of pathogenesis, and safe reliable agents with predictable activity against A. baumannii are presently nonexistent. The availability of relevant animal infection models will facilitate the study of Acinetobacter biology. In this report we tested the hypothesis that the rat pneumonia and soft-tissue infection models that our laboratory had previously used for studies of extraintestinal pathogenic Escherichia coli were clinically relevant for A. baumannii. Advantages of these models over previously described models were that the animals were not rendered neutropenic and they did not receive porcine mucin with bacterial challenge. Using the A. baumannii model pathogen 307-0294 as the challenge pathogen, the pneumonia model demonstrated all of the features of infection that are critical for a clinically relevant model: namely, bacterial growth/clearance, an ensuing host inflammatory response, acute lung injury, and, following progressive bacterial proliferation, death due to respiratory failure. We were also able to demonstrate growth of 307-0294 in the soft-tissue infection model. Next we tested the hypothesis that the soft-tissue infection model could be used to discriminate between the inherent differences in virulence of various A. baumannii clinical isolates. The ability of A. baumannii to grow and/or be cleared in this model was dependent on the challenge strain. We also hypothesized that complement is an important host factor in protecting against A. baumannii infection in vivo. In support of this hypothesis was the observation that the serum sensitivity of various A. baumannii clinical isolates in vitro roughly paralleled their growth/clearance in the soft-tissue infection model in vivo. Lastly we hypothesized that the soft-tissue infection model would serve as an efficient screening mechanism for identifying gene essentiality for drug discovery. Random mutants of 307-0294 were initially screened for lack of growth in human ascites in vitro. Selected mutants were subsequently used for challenge in the soft-tissue infection model to determine if the disrupted gene was essential for growth in vivo. Using this approach, we have been able to successfully identify a number of genes essential for the growth of 307-0294 in vivo. In summary, these models are clinically relevant and can be used to study the innate virulence of various Acinetobacter clinical isolates and to assess potential virulence factors, vaccine candidates, and drug targets in vivo and can be used for pharmacokinetic and chemotherapeutic investigations.Keywords
This publication has 51 references indexed in Scilit:
- A Step Closer to Extreme Drug Resistance (XDR) in Gram-Negative BacilliClinical Infectious Diseases, 2007
- Global Challenge of Multidrug-ResistantAcinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2007
- Trauma-related Infections in Battlefield Casualties From IraqAnnals of Surgery, 2007
- Multidrug-resistantAcinetobacterInfection Mortality Rate and Length of HospitalizationEmerging Infectious Diseases, 2007
- CAPSULE AND O-ANTIGEN FROM AN EXTRAINTESTINAL ISOLATE OFESHERICHIA COLIMODULATE CYTOKINE LEVELS IN RAT MACROPHAGES IN VITRO AND IN A RAT MODEL OF PNEUMONIAExperimental Lung Research, 2007
- Identification of Acinetobacter Species and Genotyping of Acinetobacter baumannii by Multilocus PCR and Mass SpectrometryJournal of Clinical Microbiology, 2006
- Atypical Infections in Tsunami SurvivorsEmerging Infectious Diseases, 2005
- E. colivirulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia modelAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditisClinical Microbiology & Infection, 2004
- The effects ofEscherichia colicapsule, O-antigen, host neutrophils, and complement in a rat model of Gram-negative pneumoniaFEMS Microbiology Letters, 2003